Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 1
1958 1
1961 1
1966 1
1968 1
1971 1
1981 1
1982 1
1983 1
1984 3
1986 6
1987 4
1988 1
1989 4
1990 2
1991 6
1992 6
1993 6
1994 11
1995 7
1996 9
1997 12
1998 8
1999 7
2000 12
2001 11
2002 14
2003 10
2004 12
2005 12
2006 16
2007 18
2008 14
2009 11
2010 17
2011 25
2012 16
2013 13
2014 16
2015 18
2016 19
2017 32
2018 23
2019 18
2020 23
2021 15
2022 19
2023 28
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Results by year

Filters applied: . Clear all
Page 1
Chronic cough: new insights and future prospects.
Morice A, Dicpinigaitis P, McGarvey L, Birring SS. Morice A, et al. Eur Respir Rev. 2021 Nov 30;30(162):210127. doi: 10.1183/16000617.0127-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34853095 Free PMC article. Review.
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, Hilton Boon M, Kantar A, Lai K, McGarvey L, Rigau D, Satia I, Smith J, Song WJ, Tonia T, van den Berg JWK, van Manen MJG, Zacharasiewicz A. Morice AH, et al. Eur Respir J. 2020 Jan 2;55(1):1901136. doi: 10.1183/13993003.01136-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31515408 Free PMC article.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J, Nguyen AM, Li Q, Tzontcheva A, Iskold B, Green SA, Rosa C, Muccino DR, Smith JA; COUGH-1 and COUGH-2 Investigators. McGarvey LP, et al. Among authors: morice ah. Lancet. 2022 Mar 5;399(10328):909-923. doi: 10.1016/S0140-6736(21)02348-5. Lancet. 2022. PMID: 35248186 Clinical Trial.
Drug-Induced Cough.
Shim JS, Song WJ, Morice AH. Shim JS, et al. Among authors: morice ah. Physiol Res. 2020 Mar 27;69(Suppl 1):S81-S92. doi: 10.33549/physiolres.934406. Physiol Res. 2020. PMID: 32228014 Free PMC article. Review.
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, Choudhury G, Dawson D, De Soyza A, Fielding S, Gompertz S, Haughney J, Lang CC, Lee AJ, MacLennan G, MacNee W, McCormack K, McMeekin N, Mills NL, Morice A, Norrie J, Petrie MC, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Lipworth BJ. Cotton S, et al. Among authors: morice a. Trials. 2022 Apr 14;23(1):307. doi: 10.1186/s13063-022-06226-8. Trials. 2022. PMID: 35422024 Free PMC article. Clinical Trial.
Reply to Weinberger.
Birring SS, Morice AH, Dicpinigaitis PV, McGarvey LP, Pavord ID, Green SA, Philip G, Smith JA. Birring SS, et al. Among authors: morice ah. Am J Respir Crit Care Med. 2023 Jun 15;207(12):1650-1651. doi: 10.1164/rccm.202304-0709LE. Am J Respir Crit Care Med. 2023. PMID: 37104844 Free PMC article. No abstract available.
ATP cough challenge.
Morice A. Morice A. Pulm Pharmacol Ther. 2019 Oct;58:101835. doi: 10.1016/j.pupt.2019.101835. Epub 2019 Aug 19. Pulm Pharmacol Ther. 2019. PMID: 31437483 Review. No abstract available.
475 results